Article
[Recent trends in the therapy of hepatitis C].
La Clinica terapeutica - 1 Jan 2000
Meschini A, Lucchetta M C, Fontana M, Nocchi S, Pace A, Grassi M
Abstract excerpt
The treatment of HCV correlated hepatitis is an important argument, because of the great incidence and prevalence of this disease. At the end of the Eighties, the IFN was the first substance used for HCV correlated hepatitis therapy. The IFN monotherapy with a dose of 3-6 MU for 6-12 months eradicates the infection in the 15% of cases, and cause an histological temporary improvement in a variable number of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.